Chemours Files 8-K/A Amendment
Ticker: CC · Form: 8-K/A · Filed: Dec 2, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K/A |
| Filed Date | Dec 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $600,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
Related Tickers: CC
TL;DR
Chemours filed an amendment to its 8-K, updating financial statements and exhibits.
AI Summary
The Chemours Company filed an 8-K/A on December 2, 2024, to amend a previous filing. The amendment pertains to financial statements and exhibits, with the earliest event reported being November 27, 2024. The company is incorporated in Delaware and headquartered in Wilmington, Delaware.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, likely for administrative or minor disclosure updates, rather than a significant event.
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
- Wilmington, Delaware (location) — Principal executive offices
- November 27, 2024 (date) — Date of Earliest Event Reported
- December 2, 2024 (date) — Filing Date
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing is an amendment to a previous report, specifically concerning financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 27, 2024.
What is the filing date of this 8-K/A?
This 8-K/A was filed on December 2, 2024.
Where is The Chemours Company headquartered?
The Chemours Company's principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
In which state is The Chemours Company incorporated?
The Chemours Company is incorporated in Delaware.
Filing Stats: 497 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-12-02 16:47:38
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
- $600,000,000 — the closing of its private offering of $600,000,000 aggregate principal amount of the Compa
Filing Documents
- cc-20241127.htm (8-K/A) — 49KB
- cc-ex4_1.htm (EX-4.1) — 652KB
- img172710962_0.jpg (GRAPHIC) — 35KB
- 0000950170-24-132273.txt ( ) — 1001KB
- cc-20241127.xsd (EX-101.SCH) — 30KB
- cc-20241127_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit 4.1 Third Supplemental Indenture, dated as of November 27, 2024, among The Chemours Company, the guarantors party thereto and Deutsche Bank Trust Company Americas, as trustee Exhibit 4.2 Specimen 8.000% Senior Notes Due 2033 (included in Exhibit 4.1) Exhibit 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Shane Hostetter Shane Hostetter Senior Vice President, Chief Financial Officer Date: December 2, 2024